Cover Image

Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.

Saved in:

Bibliographic Details
Main Authors:	Ulrika Marking (Author), Margriet den Boer (Author), Asish Kumar Das (Author), Elshafie Mohamed Ahmed (Author), Victoria Rollason (Author), Be-Nazir Ahmed (Author), Robert N Davidson (Author), Koert Ritmeijer (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2014-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
by: Ermias Diro, et al.
Published: (2019)

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.
by: Emiliano Lucero, et al.
Published: (2015)

Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal.
by: Anand Ballabh Joshi, et al.
Published: (2023)

Role of neutrophils in the pathogenesis of Post Kala-azar Dermal Leishmaniasis (PKDL).
by: Madhurima Roy, et al.
Published: (2024)

The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - A review and meta-analysis.
by: Joyce Pijpers, et al.
Published: (2019)

Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
by: Dinesh Mondal, et al.
Published: (2010)

Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL).
by: Gajendra Kumar Katara, et al.
Published: (2012)

Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015)

The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
by: Charles Abongomera, et al.
Published: (2018)

Correction: Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
by: V Ramesh, et al.
Published: (2015)

Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.
by: Sabrina Cencig, et al.
Published: (2011)

Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh.
by: Ridwanur Rahman, et al.
Published: (2017)

AmBisome<sup>®</sup> Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies
by: Guendalina Zuccari, et al.
Published: (2024)

PKDL--A Silent Parasite Pool for Transmission of Leishmaniasis in Kala-azar Endemic Areas of Malda District, West Bengal, India.
by: Swagata Ganguly, et al.
Published: (2015)

Cytotoxicity of Amphotericin B and AmBisome: In Silico and In Vivo Evaluation Employing the Chick Embryo Model
by: Ahmad Khosravi, et al.
Published: (2022)

Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients.
by: Gajendra Kumar Katara, et al.
Published: (2011)

Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial.
by: Eltahir A G Khalil, et al.
Published: (2014)

Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
by: Sakib Burza, et al.
Published: (2014)

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.
by: Monique Wasunna, et al.
Published: (2016)

Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis.
by: Madhurima Roy, et al.
Published: (2023)

Evaluation of Recombinase Polymerase Amplification assay for monitoring parasite load in patients with kala-azar and post kala-azar dermal leishmaniasis
by: Madhurima Roy, et al.
Published: (2023)

Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
by: Sakib Burza, et al.
Published: (2014)

Visceral Leishmaniasis (Kala-Azar) and Pregnancy
by: Ernesto Antonio Figueiró-Filho, et al.
Published: (2004)

Post kala-azar dermal leishmaniasis
by: Nilay Kanti Das
Published: (2020)

Nomadic Kala-azar in South of Iran
by: Q Asgari, et al.
Published: (2006)

Nomadic Kala-azar in South of Iran
by: Q Asgari, et al.
Published: (2006)

Oxidative Stress and Antioxidant Status in Human InfectedWith Kala-azar
by: Basma Talib Jasim, et al.
Published: (2009)

Extensive post-kala-azar dermal leishmaniasis
by: Tanvi Dev, et al.
Published: (2018)

Epidemiology of post-kala-azar dermal leishmaniasis
by: Pramit Ghosh, et al.
Published: (2021)

Histopathology of post kala-azar dermal leishmaniasis
by: V Ramesh, et al.
Published: (2020)

Availability of miltefosine for the treatment of kala-azar in India
by: Shyam Sundar, et al.
Published: (2005)

Lesiones cutáneas contemporáneas del Kala-Azar
by: Lucio Goncalo de Alcántara, et al.
Published: (1969)

Dermoscopy of post kala-azar dermal leishmaniasis
by: Abhijeet K Jha, et al.
Published: (2018)

Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform.
by: Sauman Singh-Phulgenda, et al.
Published: (2024)

Post-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
by: Eduard E Zijlstra, et al.
Published: (2017)

Immune responses in post kala-azar dermal leishmaniasis
by: Mitali Chatterjee, et al.
Published: (2020)

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)
by: Wiwanitkit V
Published: (2012)

Advancement in molecular diagnosis of post kala-azar dermal leishmaniasis
by: Keerti Kaumudee Dixit, et al.
Published: (2020)

Atypical Presentation of Post-Kala-Azar Dermal Leishmaniasis in Bhutan
by: Ambika Pradhan, et al.
Published: (2020)

Performance of kala-azar surveillance in Gaffargaon subdistrict of Mymensingh, Bangladesh.
by: Kazi Mizanur Rahman, et al.
Published: (2015)